Chung HC, Kang YK, Chen Z, Bai Y, et al. Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients. Cancer 2022;128:995-1003.
PMID: 34878659